Cytochrome oxidase activity in the monkey globus pallidus and subthalamic nucleus after ablation of striatal interneurons expressing substance P receptors

Neuroscience Letters

Volumn 353, Issue 2, 2003, Pages 103-106

  Chiken, Satomi ^a,b   Hatanaka, Nobuhiko ^a,c   Tokuno, Hironobu ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Cytochrome oxidase; Globus pallidus; Interneuron; Monkey; Parkinson's disease; Putamen; Substance P receptor; Subthalamic nucleus

Indexed keywords

CYTOCHROME C OXIDASE; NEUROTOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SUBSTANCE P RECEPTOR; SUBSTANCE P SAPORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN INJURY; CHOLINERGIC NERVE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; GLOBUS PALLIDUS; HEMISPHERE; HISTOCHEMISTRY; INHIBITION KINETICS; INJECTION; INTERNEURON; MALE; METABOLISM; MONKEY; NERVE FUNCTION; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; SUBTHALAMIC NUCLEUS;

EID: 0344665720     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.09.026     Document Type: Article

References (19)

1. Alvarez L., Macias R., Guridi J., Lopez G., Alvarez E., Maragoto C., Teijeiro J., Torres A., Pavon N., Rodriguez-Oroz M.C., Ochoa L., Hetherington H., Juncos J., DeLong M.R., Obeso J.A. Dorsal subthalamotomy for Parkinson's disease. Mov. Disord. 6:2001;72-78.
2. Chiken S., Tokuno H. Ablation of striatal interneurons influences activities of entopeduncular neurons. NeuroReport. 14:2003;675-678.
3. Kaneda K., Nambu A., Tokuno H., Takada M. Differential processing patterns of motor information via striatopallidal and striatonigral projections. J. Neurophysiol. 88:2002;1420-1432.
4. Kawaguchi Y. Neostriatal cell subtypes and their functional roles. Neurosci. Res. 27:1997;1-8.
5. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurons: chemical, physiological, and morphological characterization. Trends Neurosci. 18:1995;527-535.
6. Koós T., Tepper J.M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci. 2:1999;467-472.
7. Lappi D.A., Wiley R.G. Entering through the doors of perception: characterization of a highly selective substance P receptor-targeted toxin. Neuropeptides. 34:2000;323-328.
8. Levy R., Hazrati L.-N., Herrero M.-T., Vila M., Hassani O.-K., Mouroux M., Ruberg M., Asensi H., Agid Y., Féger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience. 76:1997;335-343.
9. Nakao N., Ogura M., Nakai K., Itakura T. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J. Neurosci. 18:1998;1806-1817.
10. Nambu A., Kaneda K., Tokuno H., Takada M. Organization of corticostriatal motor inputs in monkey putamen. J. Neurophysiol. 88:2002;1830-1842.
11. Porter R.H.P., Greene J.G., Higgins D.S. Jr., Geenamyre J.T. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci. 14:1994;7192-7199.
12. Silverman M.S., Tootell R.B.H. Modified technique for cytochrome oxidase histochemistry: increased staining intensity and compatibility with 2-deoxyglucose autoradiography. J. Neurosci. Methods. 19:1987;1-10.
13. Tokuno H., Chiken S., Kametani K., Moriizumi T. Efferent projections from the striatal patch compartment: anterograde degeneration after selective ablation of neurons expressing μ-opioid receptor in rats. Neurosci. Lett. 332:2002;5-8.
14. Tokuno H., Hatanaka N., Chiken S. Fluorescence digital photomacrography. J. Neurosci. Methods. 125:2003;7-11.
15. Tokuno H., Hatanaka N., Chiken S., Ishizuka N. An improved method with a long-shanked glass micropipette and ultrasonography for drug injection into deep brain structure of the monkey. Brain Res. Protoc. 10:2002;16-22.
16. Vila M., Levy R., Herrero M.-T., Faucheux B., Obeso J.A., Agid Y., Hirsch E.C. Metabolic activity of the basal ganglia in Parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemical study. Neuroscience. 71:1996;903-912.
17. Wichmann T., DeLong M.R. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder. Ann. N. Y. Acad. Sci. 991:2003;199-213.
18. Wiley R.G., Lappi D.A. Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats. Neurosci. Lett. 230:1997;97-100.
19. Wong-Riley M.T.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12:1989;94-101.